Seeking Alpha

Teva (TEVA -0.4%) announces the launch of generic ACTOplus met in the U.S. The drug is marketed...

Teva (TEVA -0.4%) announces the launch of generic ACTOplus met in the U.S. The drug is marketed by Takeda Pharmaceuticals and used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. ACTOplus met had annual sales of approximately $413M in the United States through June.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs